ACBM OTC
Acro Biomedical Co., Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +17.1%
1Y: +3614.3%
3Y: -99.3%
$0.03
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.6M
52W Range0.000699999975-0.1
Volume66
Avg Volume4
Beta-2.38
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJing Zhou Chen
Employees1
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2021-01-08
Websiteacrobiomedicalco.com
12175 Visionary Way
Fishers, IN 46038
US
Fishers, IN 46038
US
317 286 6788
About Acro Biomedical Co., Ltd.
Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements. The company offers products such as cordycepin and powdered cordyceps, which come from a type of fungus traditionally utilized in Chinese medicinal practices. Originally founded in 2014, the organization was known as Killer Waves Hawaii, Inc. until it rebranded as Acro Biomedical Co., Ltd. in January 2017. Its operations are headquartered in Fishers, Indiana.
Latest News
No recent news
Recent Insider Trades
No insider trades found